Vanguard Personalized Indexing Management, LLC Fate Therapeutics Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 71,364 shares of FATE stock, worth $88,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,364
Previous 43,096
65.59%
Holding current value
$88,491
Previous $34,000
132.35%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FATE
# of Institutions
146Shares Held
96.9MCall Options Held
56.7KPut Options Held
5.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$16 Million1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$12.5 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.79MShares$9.67 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.29MShares$5.32 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $120M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...